West German Centre of Diabetes and Health
Düsseldorf, 40591, Germany
NCT Number: NCT02230501
Formerly, the investigators demonstrated in an uncontrolled proof-of principle study (NCT 01680926) that protein-rich meal replacement (PRMR) was successful in reducing daily insulin demand, HbA1c and weight in type 2 diabetes mellitus (T2DM) patients injecting >100 IE insulin/day. The aim of the present study was to investigate in a randomized-controlled trial if PRMR is also effective in T2DM patients treated with oral antidiabetic medication or insulin.
A second part of the study is an open-label registry for persons with type 2 diabetes, who will perform the lifestyle intervention with the stringent diet regime.
Looking for future studies?
Notify Me25 year–79 year
All sexes
Interventional
Not applicable
Düsseldorf, 40591, Germany
Type 2 diabetes mellitus (T2DM) patients had been randomized into two groups. During the 1st week the intervention group with stringent diet regime replaced 3 main meals by 50 g PRMR (Almased-Vitalkost, Almased Wellness GmbH, Bienenbüttel, Germany) each (=1100 kcal/day). In 2nd-4th week 2 meals were replaced and a protein-rich lunch was allowed. In 5th-12th week only dinner was replaced. The control group with moderate diet regime replaced breakfast and dinner for 4 weeks and then only dinner during the next 8 weeks. Clinical parameters were determined at the study center at baseline, after 4, 8 and 12 weeks. Primary endpoint was reduction of HbA1c, secondary endpoints reduction of weight and antidiabetic medication.
In the second part of the study type 2 diabetes patients are included in an open-label reistry and perform the lifestyle intervention with the stringent diet regime.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For the open-label registry, the only inclusion criterium is type 2 diabetes.
Other names: protein-rich meal replacement (PRMR), i.e Almased-Vitalkost (Almased Wellness GmbH, Bienenbüttel, Germany)
Other names: protein-rich meal replacement (PRMR), i.e Almased-Vitalkost (Almased Wellness GmbH, Bienenbüttel, Germany)
Time frame: 12 weeks
change in hemoglobin A1c
Time frame: 1 year
change in hemoglobin A1c
Time frame: 12 weeks and 1 year
change in body weight
Time frame: 12 weeks and 1 year
change in systolic and diastolic blood pressure
Time frame: 12 weeks and 1 year
change in total cholesterol change in HDL cholesterol change in LDL cholesterol
Time frame: 12 weeks and 1 year
change in fastin g blood glucose
Time frame: 12 weeks and 1 year
change in SF-36 quality of life questionnaire change in ADS-L (German version of the general depression scale)
Time frame: 12 weeks and 1 year
change in FEV (questionnaire for eating manners)
Time frame: 12 weeks and 1 year
change in physical activity questionnaire
Time frame: 12 weeks and 1 year
West German Center of Diabetes and Health
Other
Metabolic Activation With Protein-rich Formula Diet - a Randomized-controlled Trial
Acronym: AVS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsNCT05313529
Cognition Disorders, Cognitive Dysfunction
Changzhou, Jiangsu, China
View Trial DetailsNCT05684341
Diabetes Mellitus, Diabetes Mellitus, Type 2
Changhua, Taiwan
View Trial DetailsNCT07255820
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Mellitus
Karachi, Sindh, Pakistan
View Trial Details